ArticleBlood2015

Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia.

Saradhi Mallampati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.